Genmab A/S

Genmab A/S FCF per Share

The Free Cash Flow per Share of Genmab A/S (GMAB.CO) as of Sep 26, 2026 is 2.72 USD. In the previous year, Free Cash Flow per Share was 18.21 USD — a change of -85.05% (lower).

FCF per Share

2.72USD

YoY

-85.05%

Last updated:

Free Cash Flow per Share of Genmab A/S is 2026 2.72 USD. Free Cash Flow per Share of Genmab A/S was 2025 18.21 USD. It decreases by -85.05% lower compared to the previous year.

The Genmab A/S FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2018
1.34 USD
Jan 1, 2019
2.91 USD
Jan 1, 2020
14.43 USD
Jan 1, 2021
4.64 USD
Jan 1, 2022
8.34 USD
Jan 1, 2023
16.25 USD
Jan 1, 2024
18.21 USD
Jan 1, 2025
2.72 USD
The Genmab A/S FCF per Share history
YEARFCF per ShareYoY
2.72USD-85.05%
18.21USD+12.00%
16.25USD+94.91%
8.34USD+79.77%
4.64USD-67.84%
14.43USD+395.66%
2.91USD+116.46%
1.34USD-63.16%
3.65USD+384.00%
0.75USD+64.41%
0.46USD+196.02%
0.15USD—
Access this data via the Eulerpool API
Get Free API Key

Genmab A/S Stock analysis

What does Genmab A/S do? Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab A/S stock

Free Cash Flow per Share of Genmab A/S is 2.72 USD in 2026.

Free Cash Flow per Share of Genmab A/S changed from 18.21 USD to 2.72 USD, representing a -85.05% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Genmab A/S since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API
Get Free API Key

Cash Flow — Genmab A/S

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Genmab A/S